| Literature DB >> 25642095 |
Carolina Marciela Herpich1, Ana Paula Amaral1, Ernesto Cesar Pinto Leal-Junior2, Juliana de Paiva Tosato3, Cid Andre Fidelis de Paula Gomes4, Éric Edmur Camargo Arruda1, Igor Phillip Dos Santos Glória1, Marilia Barbosa Santos Garcia1, Bruno Roberto Borges Barbosa1, Monique Sampaio Rodrigues4, Katiane Lima Silva4, Yasmin El Hage5, Fabiano Politti5, Tabajara de Oliveira Gonzalez6, Sandra Kalil Bussadori1, Daniela Aparecida Biasotto-Gonzalez1.
Abstract
The aim of the present study was to perform a systematic review of the literature on the effects of low-level laser therapy in the treatment of TMD, and to analyze the use of different assessment tools.Entities:
Keywords: Electromyography; Laser; Temporomandibular joint disorder
Year: 2015 PMID: 25642095 PMCID: PMC4305586 DOI: 10.1589/jpts.27.295
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1.Articles included in this review *The sum of articles in each category totals more than the number of articles included in the review due to the fact that some studies reported more than one outcome.
Phototherapy parameters in randomized controlled clinical trials
| Author/year of | No of | Sex and | Type of laser and | Energy density (ED) | Power density (PD) | Application | Application | Frequency and |
|---|---|---|---|---|---|---|---|---|
| Venezian et al. | 48 | 5 men/43 women | AsGaAl/Twin laser – MM | 25 J/cm² and 60 J/cm² of dose | 50 mW and | 20 and 40 s | Muscles: 3 points on | 8 sessions; 2x/week |
| Shirani et al. | 16 | 12 women/4 men, | InGaAlP/AZOR- 2K/660 nm and | 6.2 J/cm² and 1 J/cm² | 17.3 mW and | 360 s; 600 s | Trigger points of | 6 sessions: 2x/week |
| Emshoff et al. | 52 | Age 18–58 years | HeNe/Helbo Medizintechnik/ | 1.5 J/cm² | 30 mw | 120 s | Approx. 1 cm in front | 20 sessions: 2 to 3x/ |
| Carvalho et al. | 74 | 15 men/59 women, | ? /Biowave, Kondortech/660 nm | 1 to 2 J/cm² 14.2±6.8 J/cm² mean dose per session 8 J/cm2) | 30/40 mW; 40/50 mw | Indicated by equipment based on ED and PD. | 4 points near TMJ | 12 sessions: 2x/weeks for 6 weeks |
| Salmos-Brito et al. | 58 | 8 men/50 women, age 19–86 years | AsGa (Thera Laser, DMC) 830 nm | 40 mW | 60 s | 5 points around painful TMJ and condyle | 12 sessions: 2x/weeks for 6 weeks | |
| Marini et al. | 99 | 74 women/ 25 men, age 15–50 years | AsGa (LUMIX 2 HFPL Fisioline) 910 nm, pulse time < 200 ns and 50 kHz | ? | 400 mW (mean power) | 3 steps: 20 kHz for 10 min; 18 kHz for 5 min; 16 kWz for 5min | In right and left TMJ | 10 consecutive days (5 d/wk) |
| Da Cunha LA et al. | 40 | 39 women/1 man, age 20–68 years | AsGa (laser – Biolux, Bio-Art, São Carlos, SP, Brazil) 830 nm | 4 J/point | 500 mW | 20 seconds on each area | Directly over painful area | 1 x per week for 4 consecutive weeks |
| Frare et al. | 18 | Women, mean age 27 ± 7 years | GaAs laser, 904 nm (Laserplus), | 6 J/cm2 | 15 mW continuous | 16 s per point | Pre-auricular region and outer acoustic meatus | 2x per week for 4 weeks (8 sessions) |
| Hotta et al. | 10 | 9 women/1 man, mean age 35.3 years (15–67 years) | GaAs Twin Laser, MM Optics, São Carlos-SP, Brazil) 780 nm. | 35 J/cm2 | 70 mW | 20 s | Points employed in acupuncture | Once a week, 10 sessions |
| Shinozaki et al. | 13 | Women, 18–36 years | GaAs laser Bio-wave device (Kondortech) 790 nm. | 1.5 J/cm2 for TMJ, 2.5 J/cm2 for auriculo-temporal nerve, 3 J/cm2 for masseter | 40 mW | ? | TMJ, region of auriculo-temporal nerve and masseter | Single session |
| Carrasco et al. | 14 | ? | AsGaAl/Twin laser MM Optics/780 nm | Resulting in a dose of 105 J/cm² | 70 mW | 60 s | TMJ | 8 sessions: 2x/week for 4 weeks |
TMJ temporomandibular joint.
Methods, assessment tools and outcomes of randomized controlled clinical trials
| Author/year of publication | Aspect evaluated | Assessment tools | Evaluations | Outcomes | Pedro Score |
|---|---|---|---|---|---|
| Venezian et al. | Pain upon palpation, masseter and temporal muscle activity | RDC/TMD, VAS, EMG | Before, immediately after, and 30 days after treatment | No differences in EMG between groups, before and after treatment. Reduction in pain in laser group for all muscles palpated, but no statistically significant difference in comparison to placebo group. Reduction in pain lasted 30 days after end of treatment in laser group with 25 J/cm², but returned after 30 days in group with 60 J/cm². | 6 |
| Shirani et al. | Pain | VAS | Before and after 1 week, and 3 weeks of treatment | Reduction in pain in both groups, with laser proving more effective. One patient reported return of pain 1 month after end of treatment. | 6 |
| Emshoff et al. | Pain during muscle function | RDC/TMD, VAS | Before and after 2, 4, and 8 weeks of treatment | Reduction in pain in TMJ during jaw function in both groups. No statistically significant difference between groups. | 7 |
| Carvalho et al. | Pain | VAS | At the end of each of 12 sessions (comparisons only at end of treatment) | 64% of patients were asymptomatic or had improved after treatment. Combination of two wavelengths (red and infrared) achieved significant reduction in pain. | 4 |
| Salmos-Brito et al. | Pain, range of motion | RDC/TMD, VAS, digital ruler | Before first session and on second day after last session (12 sessions) | Significant improvements in pain intensity and maximal mouth opening after LLLT in groups with acute and chronic TMD. Greater improvements in group with acute TMD. | 6 |
| Da Cunha LA et al. | Pain, range of motion | Craniomandibular Index, VAS | Before first session and after last session (4 sessions) | Significant reduction in pain in both groups after treatment according to VAS scores (p < 0.05). No significant difference between groups regarding pain and symptoms of TMD according to craniomandibular index. | 7 |
| Frare et al. | Pain | RDC/TMD, clinical evaluation, VAS | Before and after therapy | Statistically significant reductions in VAS scores among sessions in treated group (p < 0.05). Significant reduction in VAS score between first and last session only in control group (p < 0.05). | 7 |
| Hotta et al. | Pain, range of motion, muscle activity | Mandibular range of motion, VAS, EMG | Before and after each treatment session | Statistically significant improvements in pain and muscle activity in masseter muscles in habitual occlusion after laser applications (p < 0.01), but no significant improvement in measures of mandibular movements (p = 0.05 + ¼). | 5 |
| Shinozaki et al. | Muscle activity | EMG | Before, immediately after, and 5 and 20 min after treatment | Reduction in EMG activity in masseter and temporal muscles in laser group. Laser therapy promoted significant relaxation of masseter muscles immediately after application. | 5 |
| Carrasco et al. | Pain, chewing efficiency | VAS, colorimetric method involving chewing capsule | After eighth application and 30 days after last application | Reduction in pain in laser group. Fewer symptoms and greater chewing efficiency after 8 sessions of laser therapy. | 5 |
| Marini et al. | Pain, range of motion | VAS, ruler, magnetic resonance | VAS: 2, 5, 10, and 15 days after treatment. Range of motion: after 15 days and 1 month of treatment. Magnetic resonance: before and after treatment | Significant reduction in pain in comparison to group using non-steroidal anti-inflammatory drugs. Magnetic resonance revealed disappearance of effusion in laser group. Mean measures of active and passive mouth opening and lateral excursion greater in laser group after treatment and 1 month later. | 5 |
RDC/TMD: Clinical Diagnostic Criteria for Temporomandibular Disorders, VAS: visual analog scale, EMG: electromyography